Evidence map›Paper›PMID 33597640›Full record

ArticleScientific reports2021

A multiwell plate-based system for toxicity screening under multiple static or cycling oxygen environments.

Ming Yao, Glenn Walker, Michael P Gamcsik

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ming YaoDepartment of Mechanical and Aerospace Engineering, NC State University, Raleigh, USA.
Glenn WalkerDepartment of Biomedical Engineering, University of Mississippi, Oxford, MS, USA.
Michael P GamcsikUNC/NCSU Joint Department of Biomedical Engineering, Campus Box 7115, Engineering Bldg 3, 1840 Entrepreneur Drive, Raleigh, NC, 27695-7115, USA. mgamcsi@ncsu.edu.
North Central State College · USUNC/NCSU Joint Department of Biomedical Engineering · USUniversity of Mississippi · US

Funding

High-Throughput Screening Under Static or Dynamic HypoxiaR21CA202804 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI GAMCSIK, MICHAEL · 2016 to 2018
$574k
NCI NIH HHS R21 CA202804
6 · The paper itself

Abstract

Tumor tissue contains a continuous distribution of static and dynamically changing oxygen environments with levels ranging from physiologically normal oxygen down to anoxia. However, in vitro studies are often performed under oxygen levels that are far higher than those found in vivo. A number of devices are available to alter the oxygen environment in cell culture, including designs from our laboratory. However, in our devices and most other designs, changing the media in order to feed or dose cells remains a disruptive factor in maintaining a consistent hypoxic environment. This report presents a novel 96-well plate design that recirculates the local oxygen environment to shield cells during media changes and facilitates toxicity studies of cells cultured under varying oxygen levels. The principle behind the design is presented and the response of human pancreatic cancer PANC-1 cells treated with tirapazamine and doxorubicin under eight different static or cycling oxygen levels was measured. As expected, tirapazamine is progressively more toxic as oxygen levels decrease but retains some toxicity as oxygen is cycled between hypoxic and normoxic levels. Doxorubicin sensitivity is largely unaffected by changing oxygen levels. This technology is ideal for assessing the effects of oxygen as a variable in toxicity screens.

Indexed as

Cell Culture TechniquesCell HypoxiaCell Line, TumorDoxorubicinHigh-Throughput Screening AssaysHumansNeoplasmsOxygenPancreatic NeoplasmsTirapazamineToxicity TestsTriazinesTumor MicroenvironmentDoxorubicinOxygenTirapazamineTriazines

Identifiers

PMID33597640
PMCPMC7890056
OpenAlexW3129840364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.